LAUSR

IM156, a new AMPK activator, protects against polymicrobial sepsis

Sign Up to like & get
recommendations!
1 Published in 2022 at "Journal of Cellular and Molecular Medicine"

DOI: 10.1111/jcmm.17341

Abstract: IM156, a novel biguanide with higher potency of AMP‐activated protein kinase activation than metformin, has inhibitory activity against angiogenesis and cancer. In this study, we investigated effects of IM156 against polymicrobial sepsis. Administration of IM156… read more here.

Keywords: sepsis; activator protects; new ampk; ampk activator ... See more keywords